CASI Pharmaceuticals (CASIF) Profit After Tax Growth (1y) (2023 - 2025)
CASI Pharmaceuticals (CASIF) Profit After Tax Growth (1y) (2023 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
860,679.92 Bn |
860,679.89 Bn |
- |
- |
| 2 |
Belite Bio |
55,284.00 Bn |
55,284.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
16,206.94 Bn |
16,206.93 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,318.00 Bn |
3,317.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,543.84 Bn |
1,543.84 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,449.11 Bn |
1,449.09 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
216.99 Bn |
216.98 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
115.22 Bn |
107.97 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
90.58 Bn |
90.58 Bn |
- |
- |
| 10 |
CASI Pharmaceuticals |
- |
- |
3.69 Mn |
-478.10% |
| Date | Value |
|---|
| Dec 31, 2025 |
-478.10% |
| Sep 30, 2025 |
-29.64% |
| Jun 30, 2025 |
-92.03% |
| Mar 31, 2025 |
212.83% |
| Dec 31, 2024 |
-117.96% |
| Sep 30, 2024 |
-87.98% |
| Jun 30, 2024 |
30.83% |
| Mar 31, 2024 |
-63.40% |
| Dec 31, 2023 |
-110.78% |
| Sep 30, 2023 |
11.09% |
| Jun 30, 2023 |
-34.39% |
| Mar 31, 2023 |
30.58% |
